$12.53
-0.24-1.88%
Pre-Market: 4:37 AM EDT
Comments
Loading...
Arcturus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARCT | Benzinga
Arcturus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$-0.450
Quarterly Revenue Estimate
$52.99M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$138.39M
Analyze the earnings history of Arcturus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARCT | Arcturus Therapeutics | -$1.00 | -$0.45 | — | — | $38.01M | $52.99M | — | — | 05/07/2025 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.32 | -$0.49 | -$1.11 | -126.53% | $33.99M | $44.64M | $22.77M | -49.00% | 03/06/2025 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.61 | -$1.22 | -$0.26 | 78.69% | $45.14M | $36.60M | $41.67M | 13.86% | 11/07/2024 | Get Alert |
| ARCT | Arcturus Therapeutics | -$1.98 | -$1.60 | -$0.64 | 60.00% | $10.52M | $21.70M | $49.86M | 129.76% | 08/05/2024 | Get Alert |
| ARCT | Arcturus Therapeutics | $1.87 | -$1.19 | -$1.00 | 15.97% | $80.28M | $17.54M | $38.01M | 116.72% | 05/08/2024 | Get Alert |
| ARCT | Arcturus Therapeutics | $4.33 | -$0.99 | -$0.32 | 67.68% | $160.29M | $37.86M | $33.99M | -10.22% | 03/07/2024 | Get Alert |
| ARCT | Arcturus Therapeutics | -$1.33 | -$1.69 | -$0.61 | 63.91% | $13.37M | $15.86M | $45.14M | 184.62% | 11/14/2023 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.82 | -$0.21 | -$1.98 | -842.86% | $27.09M | $48.50M | $10.52M | -78.31% | 08/07/2023 | Get Alert |
| ARCT | Arcturus Therapeutics | -$1.94 | $0.06 | $0.62 | 933.33% | $5.24M | $37.94M | $80.28M | 111.61% | 05/09/2023 | Get Alert |
| ARCT | Arcturus Therapeutics | -$1.47 | $0.98 | $4.33 | 341.84% | $5.79M | $72.68M | $160.29M | 120.55% | 03/28/2023 | Get Alert |
| ARCT | Arcturus Therapeutics | -$2.05 | -$1.81 | -$1.33 | 26.52% | $2.44M | $3.42M | $13.37M | 290.91% | 11/09/2022 | Get Alert |
| ARCT | Arcturus Therapeutics | -$2.07 | -$1.90 | -$0.82 | 56.84% | $2.00M | $2.09M | $27.09M | 1196.32% | 08/09/2022 | Get Alert |
| ARCT | Arcturus Therapeutics | -$2.15 | -$1.44 | -$1.94 | -34.72% | $2.13M | $6.30M | $5.24M | -16.76% | 05/09/2022 | Get Alert |
| ARCT | Arcturus Therapeutics | -$1.25 | -$1.72 | -$1.47 | 14.53% | $2.24M | — | $5.79M | — | 02/28/2022 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.92 | -$1.59 | -$2.05 | -28.93% | $2.33M | — | $2.44M | — | 11/08/2021 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.55 | -$2.14 | -$2.07 | 3.27% | $2.32M | $2.32M | $2.00M | -13.75% | 08/09/2021 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.67 | -$1.25 | -$2.15 | -72.00% | $2.65M | $2.54M | $2.13M | -16.26% | 05/10/2021 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.76 | -$0.88 | -$1.25 | -42.05% | $2.97M | $2.36M | $2.24M | -5.17% | 03/01/2021 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.56 | -$0.49 | -$0.92 | -87.76% | $3.32M | $3.00M | $2.33M | -22.23% | 11/09/2020 | Get Alert |
| ARCT | Arcturus Therapeutics | -$0.07 | -$0.55 | -$0.55 | 0.00% | $10.15M | $3.54M | $2.32M | -34.41% | 08/10/2020 | Get Alert |
| ARCT | Arcturus Therapeutics | — | -$0.61 | -$0.67 | -9.84% | — | $4.97M | $2.65M | -46.76% | 05/07/2020 | Get Alert |
Arcturus Therapeutics (ARCT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-1.11 | $-0.49 | -126.5 % |
| Q3 | 2024-11-07 | $-0.26 | $-1.22 | 78.7 % |
| Q2 | 2024-08-05 | $-0.64 | $-1.60 | 60.0 % |
| Q1 | 2024-05-08 | $-1.00 | $-1.19 | 16.0 % |
Arcturus Therapeutics (ARCT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $22.77M | $44.64M | -49.0 % |
| Q3 | 2024-11-07 | $41.67M | $36.60M | 13.9 % |
| Q2 | 2024-08-05 | $49.86M | $21.70M | 129.8 % |
| Q1 | 2024-05-08 | $38.01M | $17.54M | 116.7 % |
FAQ
When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?
Arcturus Therapeutics (ARCT) is scheduled to report earnings on May 7, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Arcturus Therapeutics (NASDAQ:ARCT)?
The Actual EPS was $-1.11, which missed the estimate of $-0.49.
What were Arcturus Therapeutics’s (NASDAQ:ARCT) revenues?
The Actual Revenue was $22.8M, which missed the estimate of $44.6M.
Browse earnings estimates, EPS, and revenue on all stocks.